Document is current
Any future updates will be listed below
-
Authors
Davíðsson, Ólafur Birgir
Curovic-Rotbain, Emelie Hamotal
Kristjánsson, Ragnar Pétur
Dietz, Jojo Biel-Nielsen
Søegaard, Signe Holst
Werling, Mikkel
Andersen, Fie Stegenborg
Dalton, Susanne
Niemann, Carsten Utoft
Melbye, Mads
Friis, Søren
Hjalgrim, Henrik
Rostgaard, Klaus
-
Funding
Funding for this research was provided by:
Kræftens Bekæmpelse (R325-A18705 and R374-A22191)
- License Information
-
More Information
Article History
Received: 6 January 2026
Accepted: 19 May 2026
First Online: 9 June 2026
Competing interests
: C.N. has received research funding and/or consultancy fees from AbbVie, AstraZeneca, Janssen, BeiGene, Genmab, Octapharma, Takeda, MSD, Lilly, CSL Behring, Galapagos, Synamics, and the Novo Nordisk Foundation. The remaining authors declare no competing interests.
